We are live on
!
Find out more
Bessemer Group Portfolio holdings
AUM
$63.6B
1-Year Est. Return
28.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.85%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$25.7B
AUM Growth
-$62.8M
(-0.24%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-0.47%
Top 10 Holdings %
Top 10 Hldgs %
18.43%
Holding
1,885
New
196
Increased
495
Reduced
475
Closed
173
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cintas
CTAS
|
+$191M |
| 2 |
Salesforce
CRM
|
+$110M |
| 3 |
Zoetis
ZTS
|
+$105M |
| 4 |
Union Pacific
UNP
|
+$101M |
| 5 |
IBM
IBM
|
+$93.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$252M |
| 2 |
Campbell Soup
CPB
|
+$155M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$116M |
| 4 |
Comcast
CMCSA
|
+$102M |
| 5 |
RTN
Raytheon Company
RTN
|
+$98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.27% |
| 2 | Technology | 14.3% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Healthcare | 11.66% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Invesco Mortgage Capital
IVR
$761M
| $1.15M | ﹤0.01% |
6,991
-3,219
| -32% | -$531K |
|
527
TE Connectivity
TEL
$59B
| $1.15M | ﹤0.01% |
11,459
-2,487
| -18% | -$251K |
|
528
Phibro Animal Health
PAHC
$1.46B
| $1.14M | ﹤0.01% |
28,600
+1,000
| +4% | +$37K |
|
529
Usana Health Sciences
USNA
$424M
| $1.13M | ﹤0.01% |
13,200
+300
| +2% | +$23.2K |
|
530
Expeditors International
EXPD
$22.3B
| $1.13M | ﹤0.01% |
17,860
+2,586
| +17% | +$166K |
|
|
MYOK
531
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.13M | ﹤0.01% |
23,148
+11,870
| +105% | +$617K |
|
532
1st Source
SRCE
$2.14B
| $1.12M | ﹤0.01% |
22,210
| – | – |
|
533
PJT Partners
PJT
$4.36B
| $1.12M | ﹤0.01% |
22,342
+300
| +1% | +$14.5K |
|
|
HIFR
534
DELISTED
InfraREIT, Inc.
HIFR
| $1.12M | ﹤0.01% |
57,500
-200
| -0.3% | -$3.8K |
|
535
Capital One
COF
$128B
| $1.11M | ﹤0.01% |
11,627
+25
| +0.2% | +$2.49K |
|
536
Primoris Services
PRIM
$4.51B
| $1.07M | ﹤0.01% |
43,022
+22
| +0.1% | +$564 |
|
|
ATRI
537
DELISTED
Atrion Corp
ATRI
| $1.07M | ﹤0.01% |
1,700
| – | – |
|
|
LMNX
538
DELISTED
Luminex Corp
LMNX
| $1.07M | ﹤0.01% |
50,600
| – | – |
|
539
Williams-Sonoma
WSM
$28B
| $1.06M | ﹤0.01% |
40,388
-14,090
| -26% | -$373K |
|
540
Sempra
SRE
$60.1B
| $1.06M | ﹤0.01% |
19,084
+1,424
| +8% | +$76.8K |
|
541
Strategic Education
STRA
$1.79B
| $1.05M | ﹤0.01% |
+10,410
| New | +$986K |
|
|
PRFT
542
DELISTED
Perficient Inc
PRFT
| $1.05M | ﹤0.01% |
45,900
+600
| +1% | +$12.4K |
|
|
SYKE
543
DELISTED
SYKES Enterprises Inc
SYKE
| $1.05M | ﹤0.01% |
36,200
+500
| +1% | +$15.2K |
|
|
TYPE
544
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $1.05M | ﹤0.01% |
46,700
+9,900
| +27% | +$238K |
|
545
CenterPoint Energy
CNP
$29B
| $1.05M | ﹤0.01% |
38,231
-205
| -0.5% | -$5.58K |
|
546
General Mills
GIS
$19.9B
| $1.04M | ﹤0.01% |
23,169
+4,804
| +26% | +$261K |
|
547
Exelon
EXC
$48.8B
| $1.02M | ﹤0.01% |
36,682
-29,795
| -45% | -$805K |
|
|
ADSW
548
DELISTED
Advanced Disposal Services Inc
ADSW
| $1.02M | ﹤0.01% |
45,800
| – | – |
|
|
CMD
549
DELISTED
Cantel Medical Corporation
CMD
| $1.01M | ﹤0.01% |
9,100
-3,900
| -30% | -$437K |
|
550
Alamo Group
ALG
$2.02B
| $1.01M | ﹤0.01% |
9,200
| – | – |
|
Similar funds
Bessemer Group's Q1 2018 Portfolio in Review
As of Q1 2018, Bessemer Group held 1,885 positions worth $25.7B, down 0.24% from $25.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bessemer Group's Q1 2018 filing shows 196 new, 495 increased, 475 reduced and 173 closed positions. Its largest new stake was Cintas: 4,607,876 shares worth $197M. The largest sale was Eli Lilly, an estimated $252M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
- Bessemer Group's largest Q1 2018 buy was Cintas: 4,607,876 shares worth $197M.
- Bessemer Group added most to Salesforce in Q1 2018, an estimated $110M increase.
- Bessemer Group's biggest Q1 2018 reduction was Eli Lilly, cutting an estimated $252M.
- Bessemer Group fully exited Validus Hold Ltd in Q1 2018, selling an estimated $19.5M.
- Bessemer Group's ten largest holdings make up 18% of its $25.7B portfolio in Q1 2018.
- Bessemer Group opened 196 new positions and closed 173 in Q1 2018.
- Bessemer Group's portfolio value fell 0.24% quarter-over-quarter to $25.7B.
Based on Bessemer Group's 13F filing for Q1 2018, filed 10 May 2018.